Abstract
Autologous stem cell transplantation (ASCT) is an effective therapy for eligible patients with immunoglobulin light chain amyloidosis (AL) and is able to induce deep and durable remissions. However, not all patients achieve a deep response after ASCT and the role of consolidation post ASCT in AL amyloidosis is not well defined.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
